The improved prognosis of <i>FLT3</i>-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data

Not available.

Saved in:
Bibliographic Details
Main Authors: Matthew Schwede, Gladys Rodriguez, Vanessa E. Kennedy, Solomon Henry, Douglas Wood, Gabriel N. Mannis, Ravindra Majeti, Jonathan H. Chen, Eran Bendavid, Tian Yi Zhang
Format: Article
Language:English
Published: Ferrata Storti Foundation 2025-02-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/11934
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825208885641740288
author Matthew Schwede
Gladys Rodriguez
Vanessa E. Kennedy
Solomon Henry
Douglas Wood
Gabriel N. Mannis
Ravindra Majeti
Jonathan H. Chen
Eran Bendavid
Tian Yi Zhang
author_facet Matthew Schwede
Gladys Rodriguez
Vanessa E. Kennedy
Solomon Henry
Douglas Wood
Gabriel N. Mannis
Ravindra Majeti
Jonathan H. Chen
Eran Bendavid
Tian Yi Zhang
author_sort Matthew Schwede
collection DOAJ
description Not available.
format Article
id doaj-art-ba970a05f5d8430ba292d0e7de292263
institution Kabale University
issn 0390-6078
1592-8721
language English
publishDate 2025-02-01
publisher Ferrata Storti Foundation
record_format Article
series Haematologica
spelling doaj-art-ba970a05f5d8430ba292d0e7de2922632025-02-06T19:45:03ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-02-01999110.3324/haematol.2024.286695The improved prognosis of <i>FLT3</i>-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record dataMatthew Schwede0Gladys Rodriguez1Vanessa E. Kennedy2Solomon Henry3Douglas Wood4Gabriel N. Mannis5Ravindra Majeti6Jonathan H. Chen7Eran Bendavid8Tian Yi Zhang9Department of Oncology, Swedish Cancer Institute, Seattle, Washington; Division of Hematology, Department of Medicine, Stanford University School of Medicine, StanfordRobert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IllinoisDivision of Blood and Marrow Transplant and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, StanfordTechnology and Digital Solutions (TDS), Research Technology, and Research Data Services at Stanford Health Care and School of Medicine, StanfordTechnology and Digital Solutions (TDS), Research Technology, and Research Data Services at Stanford Health Care and School of Medicine, StanfordDivision of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Cancer Institute, Stanford University School of Medicine, StanfordDivision of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Cancer Institute, Stanford University School of Medicine, Stanford, California; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, StanfordDivision of Hospital Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California; Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, CA; Clinical Excellence Research Center, Stanford University, Stanford, CAStanford University, Center for Health Policy, Stanford University School of Medicine, California; Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, StanfordDivision of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Cancer Institute, Stanford University School of Medicine, Stanford Not available. https://haematologica.org/article/view/11934
spellingShingle Matthew Schwede
Gladys Rodriguez
Vanessa E. Kennedy
Solomon Henry
Douglas Wood
Gabriel N. Mannis
Ravindra Majeti
Jonathan H. Chen
Eran Bendavid
Tian Yi Zhang
The improved prognosis of <i>FLT3</i>-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data
Haematologica
title The improved prognosis of <i>FLT3</i>-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data
title_full The improved prognosis of <i>FLT3</i>-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data
title_fullStr The improved prognosis of <i>FLT3</i>-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data
title_full_unstemmed The improved prognosis of <i>FLT3</i>-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data
title_short The improved prognosis of <i>FLT3</i>-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data
title_sort improved prognosis of i flt3 i internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy a real world study using large scale electronic health record data
url https://haematologica.org/article/view/11934
work_keys_str_mv AT matthewschwede theimprovedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT gladysrodriguez theimprovedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT vanessaekennedy theimprovedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT solomonhenry theimprovedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT douglaswood theimprovedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT gabrielnmannis theimprovedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT ravindramajeti theimprovedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT jonathanhchen theimprovedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT eranbendavid theimprovedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT tianyizhang theimprovedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT matthewschwede improvedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT gladysrodriguez improvedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT vanessaekennedy improvedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT solomonhenry improvedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT douglaswood improvedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT gabrielnmannis improvedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT ravindramajeti improvedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT jonathanhchen improvedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT eranbendavid improvedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata
AT tianyizhang improvedprognosisofiflt3iinternaltandemduplicationbutnottyrosinekinasedomainmutationsinacutemyeloidleukemiaintheeraoftargetedtherapyarealworldstudyusinglargescaleelectronichealthrecorddata